Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review

摘要

Study selection process for the systematic literature review and meta-analysis of breast cancer ( ). *Exclusions include not phase II, not phase III or phase II with triple-negative breast cancer ( ) focus, phase II not TNBC focus, not phase II or phase III, and not TNBC focus phase II/I. Exclusions include review articles, other study types, not recurrent/metastatic ( ) of phase III/II data, and not TNBC-specific R/M. Exclusions include non-cancer outcomes focus, only quality-of-life data, study protocol, surgical intervention, model development, and only AE data. Exclusions include other language, older report of the same study, and reference unavailable. Results from one study (phase III trial, study 301) based on internal communication with sponsor (Eisai); not published results. Results from Twelves et al.’s [ ] and Pivot et al.’s [ ] studies are both included based on the reported different treatment line outcomes